DESIGNING A GLOBAL CANCER FINANCING SYSTEMSO THAT NO ONE IS LEFT BEHIND
We are launching the Global Cancer Financing Platform — a bold new platform to mobilize at least $1Billion by 2030 to shift cancer diagnosis from late to early stage, where survival is higher and treatment is more affordable.
Financing the shift to equity in cancer outcomes
Our focus is stage shifting: moving more patients into early-stage diagnosis, when treatment is most effective and survival is highest. By starting with women’s cancers, we will prioritize areas of greatest inequity - while building an innovative financing platform designed for the future of global cancer care.
The cancer burden is shifting - financing hasn’t
Cancer is now a leading cause of premature death in over 70 countries. Yet less than 5% of global health financing reaches low-and-middle income countries, where cases are rising fastest. Too often, cancers are detected late, when survival is low and costs are high. We believe a new financing model can change that trajectory.
Cancer is the leading cause of premature death.
Reaches LMIC cancer care.
In many LMIC settings.
When cancers are found early.
From proven solutions to transformative innovations
The Platform will invest in trusted interventions such as HPV vaccination and testing, community-based screening, diagnostics, and patient navigation. It will also accelerate next-generation tools including AI-assisted triage, portable imaging, interoperable data platforms, and self-collection technologies to move detection and care earlier in the continuum.
By linking these investments directly to treatment access, the Platform ensures early detection leads to lifesaving care—not just diagnosis. The same systems and capabilities established for cervical cancer will adapt and scale to breast and other high-burden cancers.
Core design elements
National investment plans co-developed with governements and aligned to National Cancer Care Plans.
Blended resources from domestic budgets, philanthropy, multilaterals, diaspora/remittances, and outcome-linked instruments.
Disbursements tied to verified outcomes, with digital dashboards and open reporting on services and results.
Independent technical review, audit, and governance structures to uphold quality and equity.
Seizing the moment for global cancer equity
For more than two decades, the global cancer community has called for a financing mechanism that matches the scale of the challenge. Yet progress has been constrained by a fragile and fragmented funding landscape, leaving countries without the tools to act decisively.
The Global Cancer Financing Platform is designed to turn this momentum into lasting systems change. By creating a country-led, transparent, and outcomes-focused platform, we can align resources, scale proven solutions, and accelerate innovation. Now is the time to build a financing model that not only delivers immediate impact, but also lays the foundation for sustainable cancer control worldwide.
What defines our approach
Investments must reach the communities in LMICs most underserved by current cancer systems and markets.
Solutions must be aligned with national strategies, institutions, and health priorities.
The Fund must strengthen long-term capacity, not create parallel systems or one-off interventions.
Cancer care must be embedded in primary health systems, digital health platforms, and universal health coverage efforts.
The Fund should unlock co-investment, drive policy change, and create systems-level shifts—not just fund projects.
Early milestones
2025: Establish governance, publish framework, and raise seed commitments.
2026: Co-design 3–5 country investment notes; pilot transparency dashboard.
2027: Expand to additional countries and scale blended capital mechanisms.
2030: Mobilize $1B and demonstrate measurable stage-shift at national scale.
Help shape the Global Cancer Fund
This is the beginning. We invite governments, funders, clinicians, advocates, and innovators to add their perspective as we refine and expand the platform.